Monday, March 26, 2012

TheraVida Raises $8.9M

Mountain View-based TheraVida, a developer of drugs to treat overactive bladder and urinary incontinence, has now raised $8.9M in its latest funding round, according to a recent regulatory filing from the firm. Details on the funding have not been announced by the company. According to the filing, the Series A-2 preferred stock financing is part of an ongoing, $12.3M funding effort by the company, which kicked off in June of 2010. The filings indicate $3.6M of the round was raised back in 2010. More information »